These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15156891)

  • 1. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs.
    Noah L
    S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening the supply of routinely recommended vaccines in the United States: a perspective from the American Medical Association.
    Tan L;
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S121-4. PubMed ID: 16447133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notes and comments "High and dry?" The Public Readiness and Emergency Preparedness Act and liability protection for pharmaceutical manufacturers.
    Copper BK
    J Health Law; 2007; 40(1):65-105. PubMed ID: 17549932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism and implication of regulation of the pricing of essential medicines in the private pharmaceutical sector in Mali].
    Maïga D; Maïga S; Maïga MD
    Med Trop (Mars); 2010 Apr; 70(2):184-8. PubMed ID: 20486360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public-private partnerships for health: their main targets, their diversity, and their future directions.
    Widdus R
    Bull World Health Organ; 2001; 79(8):713-20. PubMed ID: 11545327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The U.S. vaccine supply.
    Schwartz HK
    N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15762001
    [No Abstract]   [Full Text] [Related]  

  • 9. Tort claims and federal regulation of medical devices vs pharmaceuticals.
    Green M
    JAMA; 2009 Sep; 302(11):1169; author reply 1169-70. PubMed ID: 19755694
    [No Abstract]   [Full Text] [Related]  

  • 10. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving vaccine supply and development: who needs what?
    Pauly MV
    Health Aff (Millwood); 2005; 24(3):680-9. PubMed ID: 15886159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
    Resnik DB; DeVille KA
    Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
    [No Abstract]   [Full Text] [Related]  

  • 13. Not taking, just borrowing: government use of patented drugs.
    Ossorio PN
    Am J Bioeth; 2002; 2(3):51-2. PubMed ID: 12230861
    [No Abstract]   [Full Text] [Related]  

  • 14. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
    Breslow LH
    Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cipro patent and bioterrorism.
    Kaye KS; Kaye D
    Am J Bioeth; 2002; 2(3):41-2. PubMed ID: 12230854
    [No Abstract]   [Full Text] [Related]  

  • 16. The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902.
    Lilienfeld DE
    Perspect Biol Med; 2008; 51(2):188-98. PubMed ID: 18453724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compulsory licensure: the case of Cipro and beyond.
    Chakrabarty AM
    Am J Bioeth; 2002; 2(3):40. PubMed ID: 12230853
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy implications of drug importation.
    Palumbo FB; Mullins CD; Slagle AF; Rizer J
    Clin Ther; 2007 Dec; 29(12):2758-67. PubMed ID: 18201594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It is not unethical, though it is often unwise, to override patents.
    Leventer H
    Am J Bioeth; 2002; 2(3):50-1. PubMed ID: 12230860
    [No Abstract]   [Full Text] [Related]  

  • 20. The fragility of the U.S. vaccine supply.
    Sloan FA; Berman S; Rosenbaum S; Chalk RA; Giffin RB
    N Engl J Med; 2004 Dec; 351(23):2443-7. PubMed ID: 15575064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.